Finance

Lists
531146:BOM
Medicamen Biotech Ltd
₹280.15
+3.55%
(+9.60) 1D
Sep 7, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531146...
Open
₹270.55
High
₹286.55
Low
₹265.00
Mkt. cap
3.80B
Avg. vol.
0.00
Volume
9.06K
Dividend
0.36%
Quarterly dividend
₹0.25
Ex-dividend date
Sep 18, 2026
P/E ratio
35.25
52-wk high
₹454.00
52-wk low
₹210.10
EPS
₹7.95
Shares outstanding
11.70M
No. of employees
376
Open
₹270.55
High
₹286.55
Low
₹265.00
Mkt. cap
3.80B
Avg. vol.
0.00
Volume
9.06K
Dividend
0.36%
Quarterly dividend
₹0.25
Ex-dividend date
Sep 18, 2026
P/E ratio
35.25
52-wk high
₹454.00
52-wk low
₹210.10
EPS
₹7.95
Shares outstanding
11.70M
No. of employees
376
About Medicamen Biotech Ltd
CEO-
Employees376
Founded1993
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
475.43M
474.43M
623.82M
487.58M
Cost of goods sold
231.53M
237.10M
321.96M
211.20M
Cost of revenue
231.53M
237.10M
321.96M
211.20M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
88.31M
83.73M
93.99M
93.14M
Operating expense
207.18M
206.51M
247.43M
242.38M
Total operating expenses
438.71M
443.61M
569.39M
453.58M
Operating income
36.72M
30.83M
54.43M
34.01M
Other non operating income
-
1.00K
-1.00K
-
EBT including unusual items
26.83M
21.11M
50.60M
25.72M
EBT excluding unusual items
26.83M
21.11M
50.60M
25.72M
Income tax expense
5.69M
4.76M
6.13M
7.26M
Effective tax rate
21.19%
22.56%
12.11%
28.22%
Other operating expenses
100.30M
104.51M
136.10M
131.37M
Net income
26.67M
21.87M
38.57M
21.18M
Net profit margin
5.61%
4.61%
6.18%
4.34%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-9.89M
-9.72M
-3.83M
-8.29M
Net interest expenses
-9.89M
-9.72M
-3.83M
-8.29M
Depreciation and amortization charges
18.57M
18.27M
17.33M
17.87M
EBITDA
55.01M
48.10M
72.47M
52.05M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps